For research use only. Not for therapeutic Use.
Dimethyl biphenyl-4,4/’-dicarboxylate is a planar biphenyldicarboxylic acid ester used as a hepatoprotectant in the treatment of chronic hepatitis. At 250 µg/ml, it has been shown to stimulate JAK/STAT signaling and to induce the expression of interferon-α stimulated genes in a HepG2 cell line.
Catalog Number | R065647 |
CAS Number | 792-74-5 |
Synonyms | Biphenyl dimethyl dicarboxylate |
Molecular Formula | C16H14O4 |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | methyl 4-(4-methoxycarbonylphenyl)benzoate |
InChI | InChI=1S/C16H14O4/c1-19-15(17)13-7-3-11(4-8-13)12-5-9-14(10-6-12)16(18)20-2/h3-10H,1-2H3 |
InChIKey | BKRIRZXWWALTPU-UHFFFAOYSA-N |
SMILES | COC(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)OC |
Reference | 1.Joo, S.S.,Won, T.J.,Kim, M.J., et al. Interferon signal transduction of biphenyl dimethyl dicarboxylate/amantadine and anti-HBV activity in HepG2 2.2.15. Archives of Pharmacal Research 29(5), 405-411 (2006). |